{
  "pmcid": "7431269",
  "sha256": "0db378429e13b20d4053444c4c7fe01536ed7ae8df8cf1cabc6fcf8b18c5ad6a",
  "timestamp_utc": "2025-11-09T22:55:08.758775+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 12.577611218568666,
    "reading_ease": 23.912954545454568,
    "word_count": 235
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "A Randomised Controlled Trial of Bicruciate-Retaining versus Cruciate-Retaining Total Knee Arthroplasty"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "In this parallel-group trial (ClinicalTrials.gov: NCT01966848), 50 patients with intact ACLs undergoing TKA were randomised"
      },
      "Participants": {
        "score": 2,
        "evidence": "50 patients with intact ACLs undergoing TKA"
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomised to receive either bicruciate-retaining or cruciate-retaining TKA"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study evaluates tibial component migration and patient-reported outcomes."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was maximum total point motion (MTPM) of the tibial component at 2 years"
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was computer-generated, and patients were blinded to allocation."
      },
      "Blinding": {
        "score": 1,
        "evidence": "patients were blinded to allocation"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "50 patients with intact ACLs undergoing TKA were randomised"
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "At 2 years, 22 bicruciate-retaining and 23 cruciate-retaining patients were analysed."
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "No significant difference in MTPM was found (median MTPM: 0.52 mm vs. 0.42 mm, p = 0.63)."
      },
      "Harms": {
        "score": 1,
        "evidence": "Three bicruciate-retaining patients required arthroscopic manipulation, and one had a tibial fracture requiring revision."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "ClinicalTrials.gov: NCT01966848"
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified."
      }
    },
    "total_score": 19,
    "max_score": 25
  }
}